(Q46977123)

27 December 2017

title

Melatonin attenuates phenytoin sodium-induced DNA damage (English)

1 reference

27 December 2017

0 references

1 reference

Ufuk Erenberk

1 reference

27 December 2017

Rusen Dundaroz

1 reference

27 December 2017

Ozlem Gok

1 reference

27 December 2017

Omer Uysal

1 reference

27 December 2017

Sami Agus

1 reference

27 December 2017

Adnan Yuksel

1 reference

27 December 2017

Bayram Yilmaz

1 reference

27 December 2017

Ulkan Kilic

1 reference

27 December 2017

publication date

30 October 2013

1 reference

27 December 2017

Drug and Chemical Toxicology

published in

1 reference

27 December 2017

volume

1 reference

27 December 2017

issue

1 reference

27 December 2017

page(s)

233-239

1 reference

27 December 2017

Antiepileptic drugs and apoptosis in the developing brain.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Comet assay in human biomonitoring studies: reliability, validation, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Effects of melatonin treatment in septic newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of melphalan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Statistical issues in the use of the comet assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Lymphoblastic lymphoma following prenatal exposure to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Genotoxic effects of PCB 52 and PCB 77 on cultured human peripheral lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin protects against gentamicin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Cancer risk in people with epilepsy: the role of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

Oxidative Stress-Induced Homologous Recombination As a Novel Mechanism for Phenytoin-Initiated Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480545.2013.838777

10.3109/01480545.2013.838777

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017